Pigmentary and Other Dermatologic Manifestations of Minocycline: a reminder of adverse effects

Authors

Kayla Rodriguez, Joan C. Edwards SOM, Marshall UniversityFollow
Courtney Wellman, Joan C Edwards SOM, Marshall UniversityFollow
Adam M. Franks, Joan C. Edwards SOM, Marshall UniversityFollow
Kimberly McClelland, Joan C. Edwards SOM, Marshall UniversityFollow
Tammy Bannister, Joan C. Edwards SOM, Marshall UniversityFollow

Author Credentials

Kayla Rodriguez BS Courtney Wellman MD Adam M. Franks MD Kimberly McClelland MD, MPH, MBA Tammy Bannister MD

Keywords

Minocycline, Minocycline Toxicity, Hyperpigmentation

Disciplines

Medicine and Health Sciences

Abstract

The applications of the tetracycline class of antibiotics extends beyond their antimicrobial activity to anti-inflammatory, immunosuppressive and neuroprotective applications making it a commonly used class of medication. Minocycline, a second generation tetracycline, has inherent characteristics that improve absorption and distribution. These benefits promote even more wide spread use. This familiarity of usage breeds prescriptive complacency toward the dermatologic complications including hyperpigmentation. The following case explores these adverse manifestations of Minocycline use.

Recommended Citation

Rodriguez K, Wellman C, Franks AM, McClelland K, Bannister T. Pigmentary and Other Dermatologic Manifestations of Minocycline: a reminder of adverse effects. Marshall J Med. 2019; 5(4): 21 DOI: https://doi.org/10.33470/2379-9536.1233.